Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension

Journal of Neuroinflammation

Joseph Francis²  Ryoichi Teruyama³  Deepmala Agarwal¹  Rahul B Dange² 

[1] William Hansel Cancer Prevention Laboratory, Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge 70808, LA, USA;Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, 1909 Skip Bertman Drive, Baton Rouge 70803, LA, USA;Department of Biological Sciences, College of Science, Louisiana State University, 202 Life Sciences Building, Baton Rouge 70803, LA, USA

关键词: NFκB;    IL-10;    Cytokines;    TLR4;    Hypertension;    Paraventricular nucleus;   

Others  :  1133041
DOI  :  10.1186/s12974-015-0242-7

 received in 2014-08-08, accepted in 2015-01-10,  发布年份 2015

【 摘 要 】

Background

Despite the availability of several antihypertensive medications, the morbidity and mortality caused by hypertension is on the rise, suggesting the need for investigation of novel signaling pathways involved in its pathogenesis. Recent evidence suggests the role of toll-like receptor (TLR) 4 in various inflammatory diseases, including hypertension. The role of the brain in the initiation and progression of all forms of hypertension is well established, but the role of brain TLR4 in progression of hypertension has never been explored. Therefore, we investigated the role of TLR4 within the paraventricular nucleus (PVN; an important cardioregulatory center in the brain) in an animal model of human essential hypertension. We hypothesized that a TLR4 blockade within the PVN causes a reduction in mean arterial blood pressure (MAP), inflammatory cytokines and sympathetic drive in hypertensive animals.

Methods

Spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto (WKY) rats were administered either a specific TLR4 blocker, viral inhibitory peptide (VIPER), or control peptide in their PVN for 14 days. MAP was recorded continuously by radiotelemetry. PVN and blood were collected for the measurement of pro-inflammatory cytokines (Tumor Necrosis Factor (TNF)-α, interleukin (IL)-1β), anti-inflammatory cytokine IL-10, inducible nitric oxide synthase (iNOS), TLR4, nuclear factor (NF) κB activity and plasma norepinephrine (NE) and high mobility group box (HMGB)1 expression, respectively.

Results

Hypertensive rats exhibited significantly higher levels of TLR4 in the PVN. TLR4 inhibition within the PVN attenuated MAP, improved cardiac hypertrophy, reduced TNF-α, IL-1β, iNOS levels, and NFκB activity in SHR but not in WKY rats. These results were associated with a reduction in plasma NE and HMGB1 levels and an increase in IL-10 levels in SHR.

Conclusions

This study demonstrates that TLR4 upregulation in PVN plays an important role in hypertensive response. Our results provide mechanistic evidence that hypertensive response in SHR are mediated, at least in part, by TLR4 in the PVN and that inhibition of TLR4 within the PVN attenuates blood pressure and improves inflammation, possibly via reduction in sympathetic activity.

【 授权许可】

   
2015 Dange et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al.: Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-215.
• [2]Michel MC, Brodde OE, Insel PA: Peripheral adrenergic receptors in hypertension. Hypertension 1990, 16:107-20.
• [3]Bomfim GF, Dos Santos RA, Oliveira MA, Giachini FR, Akamine EH, Tostes RC, et al.: Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci 2012, 122:535-43.
• [4]Sriramula S, Haque M, Majid DS, Francis J: Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008, 51:1345-51.
• [5]Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, et al.: Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats. BMC Cardiovasc Disord 2002, 2:3. BioMed Central Full Text
• [6]Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, et al.: NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000, 35:193-201.
• [7]Coban E, Nizam I, Topal C, Akar Y: The association of low-grade systemic inflammation with hypertensive retinopathy. Clin Exp Hypertens 2010, 32:528-31.
• [8]Abboud FM, Harwani SC, Chapleau MW: Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Hypertension 2012, 59:755-62.
• [9]Ryan MJ: An update on immune system activation in the pathogenesis of hypertension. Hypertension 2013, 62:226-30.
• [10]Zubcevic J, Waki H, Raizada MK, Paton JF: Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension. Hypertension 2011, 57:1026-33.
• [11]Jennings JR, Zanstra Y: Is the brain the essential in hypertension? Neuroimage 2009, 47:914-21.
• [12]Leow-Dyke S, Allen C, Denes A, Nilsson O, Maysami S, Bowie AG, et al.: Neuronal Toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J Neuroinflammation 2012, 9:230. BioMed Central Full Text
• [13]Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-7.
• [14]Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998, 95:588-93.
• [15]Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5:331-42.
• [16]Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010; Volume (2010), article ID 672395:1-21.
• [17]Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1-5.
• [18]Davisson RL, Oliverio MI, Coffman TM, Sigmund CD: Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 2000, 106:103-6.
• [19]Cardinale JP, Sriramula S, Mariappan N, Agarwal D, Francis J: Angiotensin II-induced hypertension is modulated by nuclear factor-kappaBin the paraventricular nucleus. Hypertension 2012, 59:113-21.
• [20]Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, et al.: Brain microglial cytokines in neurogenic hypertension. Hypertension 2010, 56:297-303.
• [21]Shi Z, Gan XB, Fan ZD, Zhang F, Zhou YB, Gao XY, et al.: Inflammatory cytokines in paraventricular nucleus modulate sympathetic activity and cardiac sympathetic afferent reflex in rats. Acta Physiol (Oxf) 2011, 203:289-97.
• [22]Hong HJ, Loh SH, Yen MH: Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase. Br J Pharmacol 2000, 131:631-7.
• [23]Agarwal D, Elks CM, Reed SD, Mariappan N, Majid DSA, Francis J: Chronic exercise preserves renal structure and hemodynamics in spontaneously hypertensive rats. Antioxid Redox Signal 2012, 16:139-52.
• [24]Stack J, Bowie AG: Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions. J Biol Chem 2012, 287:22672-82.
• [25]Oda S, Franklin E, Khan AR: Poxvirus A46 protein binds to TIR domain-containing Mal/TIRAP via an alpha-helical sub-domain. Mol Immunol 2011, 48:2144-50.
• [26]Dhandapani S, Dhandapani M, Agarwal M, Chutani AM, Subbiah V, Sharma BS, et al.: The prognostic significance of the timing of total enteral feeding in traumatic brain injury. Surg Neurol Int 2012, 3:31.
• [27]Agarwal D, Dange RB, Vila J, Otamendi AJ, Francis J: Detraining differentially preserved beneficial effects of exercise on hypertension: effects on blood pressure, cardiac function, brain inflammatory cytokines and oxidative stress. PLoS One 2012, 7(12):e52569.
• [28]Paxinos G, Watson C: The rat brain in stereotaxic coordinates. 6th edition. Academic Press/Elsevier, Amsterdam ; Boston; 2007.
• [29]Palkovits M: Punch sampling biopsy technique. Methods Enzymol 1983, 103:368-76.
• [30]Sriramula S, Cardinale JP, Francis J: Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS One 2013, 8:e63847.
• [31]Agarwal D, Haque M, Sriramula S, Mariappan N, Pariaut R, Francis J: Role of proinflammatory cytokines and redox homeostasis in exercise-induced delayed progression of hypertension in spontaneously hypertensive rats. Hypertension 2009, 54:1393-400.
• [32]Agarwal D, Welsch MA, Keller JN, Francis J: Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR. Basic Res Cardiol 2011, 106:1069-85.
• [33]Lin S, Yin Q, Zhong Q, Lv FL, Zhou Y, Li JQ, et al.: Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation 2012, 9:46. BioMed Central Full Text
• [34]Swanson LW, Kuypers HG: The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol 1980, 194:555-70.
• [35]Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-45.
• [36]Akira S: Toll receptor families: structure and function. Semin Immunol 2004, 16:1-2.
• [37]Vallejo JG: Role of toll-like receptors in cardiovascular diseases. Clin Sci (Lond) 2011, 121:1-10.
• [38]Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, et al.: Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999, 104:271-80.
• [39]Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, et al.: Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 2007, 104:13798-803.
• [40]Dange RB, Agarwal D, Masson GS, Vila J, Wilson B, Nair A, et al.: Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension. Cardiovasc Res 2014, 103:17-27.
• [41]Ji Y, Liu J, Wang Z, Liu N: Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem 2009, 23:265-76.
• [42]Chen QH, Andrade MA, Calderon AS, Toney GM: Hypertension induced by angiotensin II and a high salt diet involves reduced SK current and increased excitability of RVLM projecting PVN neurons. J Neurophysiol 2010, 104:2329-37.
• [43]Sonner PM, Lee S, Ryu PD, Lee SY, Stern JE: Imbalanced K+ and Ca2+ subthreshold interactions contribute to increased hypothalamic presympathetic neuronal excitability in hypertensive rats. J Physiol 2011, 589:667-83.
• [44]Ogawa K, Hirooka Y, Kishi T, Ide T, Sunagawa K: Partially silencing brain toll-like receptor 4 prevents in part left ventricular remodeling with sympathoinhibition in rats with myocardial infarction-induced heart failure. PLoS One 2013, 8:e69053.
• [45]Eissler R, Schmaderer C, Rusai K, Kuhne L, Sollinger D, Lahmer T, et al.: Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens Res 2011, 34:551-8.
• [46]Boissiere J, Eder V, Machet MC, Courteix D, Bonnet P: Moderate exercise training does not worsen left ventricle remodeling and function in untreated severe hypertensive rats. J Appl Physiol 2008, 104:321-7.
• [47]Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, et al.: Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 2004, 128:170-9.
• [48]Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, et al.: Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008, 28:927-38.
• [49]Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM, et al.: Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res 2009, 82:503-12.
• [50]Lu Y, Chen J, Yin X, Zhao H: Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1 beta in the paraventricular nucleus. Neurol Res 2009, 31:420-4.
• [51]Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, et al.: Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006, 114:I270-4.
• [52]Dias FA, Urboniene D, Yuzhakova MA, Biesiadecki BJ, Pena JR, Goldspink PH, et al.: Ablation of iNOS delays cardiac contractile dysfunction in chronic hypertension. Front Biosci (Elite Ed) 2010, 2:312-24.
• [53]Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al.: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000, 192:565-70.
• [54]Fu YC, Chi CS, Yin SC, Hwang B, Chiu YT, Hsu SL: Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNF alpha-caspase signaling pathway. Cardiovasc Res 2004, 62:558-67.
• [55]Gupta MK, Neelakantan TV, Sanghamitra M, Tyagi RK, Dinda A, Maulik S, et al.: An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts. Antioxid Redox Signal 2006, 8:1081-93.
• [56]Kang YM, Gao F, Li HH, Cardinale JP, Elks C, Zang WJ, et al.: NF-kappaB in the paraventricular nucleus modulates neurotransmitters and contributes to sympathoexcitation in heart failure. Basic Res Cardiol 2011, 106:1087-97.
• [57]Hedayat M, Netea MG, Rezaei N: Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect Dis 2011, 11:702-12.
• [58]Akira S: Toll-like receptor signaling. J Biol Chem 2003, 278:38105-8.
• [59]Salomao R, Brunialti MK, Rapozo MM, Baggio-Zappia GL, Galanos C, Freudenberg M: Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock 2012, 38:227-42.
• [60]Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, et al.: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001, 167:5887-94.